Kim P. Kamdar, Director at Evofem Biosciences, Inc. (EVFM), sold 10 shares at $0.62 ($6) on 2023-12-21, disclosed to the SEC on 2023-12-22.
Open-market sale of $6 EVFM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EVFM | BUY | 2020-06-16 | $15K | — | Filing → |
| OBLN | BUY | 2019-08-08 | $50K | — | Filing → |
| EVFM | SELL | 2019-05-23 | $3K | — | Filing → |